Literature DB >> 29426962

Histopathological findings of pregnancy-induced hypertension: histopathology of early-onset type reflects two-stage disorder theory.

Ayako Tateishi1, Satoshi Ohira2, Yoichiro Yamamoto3,4, Hiroyuki Kanno3.   

Abstract

The placental tissues of pregnancy-induced hypertension (PIH) patients exhibit multiple infarctions, acute atherosis, distal villous hypoplasia, and increased syncytial knots. However, these findings are not observed in all cases of PIH; thus, the significance of these changes in PIH is still unclear. We studied the frequency of histopathological changes of placental tissue in the subgroups of PIH, such as mild and severe PIH and early-onset (< 34 weeks) and late-onset (≥ 34 weeks) PIH. One hundred seven cases of PIH diagnosed at the Shinshu University Hospital, Matsumoto, Japan, between 2008 and 2014 were collected. PIH includes preeclampsia and gestational hypertension. The pathologic changes evaluated in the placenta were multiple infarctions, acute atherosis, distal villous hypoplasia, and increased syncytial knots. Placental tissues of patients with early-onset PIH demonstrated acute atherosis resulting from the incomplete remodeling of the spiral arteries and distal villous hypoplasia and increased syncytial knots reflecting placental hypoxia/ischemia much more frequently than those with late-onset PIH (all p < 0.001). The frequencies of multiple infarctions did not show a statistical difference between early-onset PIH and late-onset PIH. Moreover, there were no significant differences in the frequencies of histopathological features of placental tissue between mild PIH and severe PIH. Early-onset PIH exhibited histopathological changes of placental tissue consistent with the two-stage disorder theory more frequently than late-onset PIH. These findings support the idea that early-onset PIH and late-onset PIH are distinct entities or different extremes of the PIH spectrum.

Entities:  

Keywords:  Placenta; Preeclampsia; Pregnancy-induced hypertension; Two-stage disorder theory

Mesh:

Year:  2018        PMID: 29426962     DOI: 10.1007/s00428-018-2315-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

1.  Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns.

Authors:  Raymond W Redline; Theonia Boyd; Valarie Campbell; Scott Hyde; Cynthia Kaplan; T Yee Khong; Heather R Prashner; Brenda L Waters
Journal:  Pediatr Dev Pathol       Date:  2004-03-17

2.  Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease.

Authors:  Sarka Lisonkova; K S Joseph
Journal:  Am J Obstet Gynecol       Date:  2013-08-22       Impact factor: 8.661

3.  Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation.

Authors:  A T Papageorghiou; C K Yu; R Bindra; G Pandis; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2001-11       Impact factor: 7.299

4.  Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler.

Authors:  T Arakaki; J Hasegawa; M Nakamura; S Hamada; M Muramoto; H Takita; K Ichizuka; A Sekizawa
Journal:  Ultrasound Obstet Gynecol       Date:  2015-05       Impact factor: 7.299

5.  Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.

Authors:  Gordon C S Smith; Emily J Stenhouse; Jennifer A Crossley; David A Aitken; Alan D Cameron; J Michael Connor
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

6.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  The two stage model of preeclampsia: variations on the theme.

Authors:  J M Roberts; C A Hubel
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

8.  The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.

Authors:  Cilene Carlos Pinheiro; Patricia Rayol; Luiz Gozzani; Luciene Machado dos Reis; Gianfranco Zampieri; Cristiane Bitencourt Dias; Viktoria Woronik
Journal:  Prenat Diagn       Date:  2014-07-02       Impact factor: 3.050

9.  First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.

Authors:  Asma Khalil; Nicholas J Cowans; Kevin Spencer; Sergey Goichman; Hamutal Meiri; Kevin Harrington
Journal:  Prenat Diagn       Date:  2009-08       Impact factor: 3.050

10.  First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia.

Authors:  Aditi R Saxena; Ellen W Seely; Janet W Rich-Edwards; Louise E Wilkins-Haug; S Ananth Karumanchi; Thomas F McElrath
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-04       Impact factor: 3.007

View more
  5 in total

1.  Long noncoding RNA urothelial carcinoma associated 1 protects human placental vascular endothelial cells from hypoxia-induced damage by regulating the miR-197-3p/histone deacetylase-2 axis in patients with pregnancy-induced hypertension.

Authors:  Jie Li; Yiling Lu; Ying Wang; Xiaoyu Wang; Xinyi Kang; Weichun Tang; Liping Chen
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  The potential value of diagnostic and predictive serum biomarkers for preeclampsia.

Authors:  Anda Lorena Dijmărescu; Lidia Boldeanu; Mirela Radu; Ionela Rotaru; Mirela Anişoara Siminel; Maria Magdalena Manolea; Sidonia Cătălina Vrabie; Marius Bogdan Novac; Mihail Virgil Boldeanu; Florentina Tănase
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

3.  The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia.

Authors:  Alejandra Abascal-Saiz; Marta Duque-Alcorta; Victoria Fioravantti; Eugenia Antolín; Eva Fuente-Luelmo; María Haro; María P Ramos-Álvarez; Germán Perdomo; José L Bartha
Journal:  Nutrients       Date:  2022-05-23       Impact factor: 6.706

Review 4.  Acute Atherosis Lesions at the Fetal-Maternal Border: Current Knowledge and Implications for Maternal Cardiovascular Health.

Authors:  Daniel Pitz Jacobsen; Heidi Elisabeth Fjeldstad; Guro Mørk Johnsen; Ingrid Knutsdotter Fosheim; Kjartan Moe; Patji Alnæs-Katjavivi; Ralf Dechend; Meryam Sugulle; Anne Cathrine Staff
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

5.  Expression and role of miR-338-3p in peripheral blood and placenta of patients with pregnancy-induced hypertension.

Authors:  Jun Li; Yan Wu; Hui Liu
Journal:  Exp Ther Med       Date:  2020-05-06       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.